Southern California Res. Ctr /ID# 265549, Coronado
UC San Diego Health System /ID# 265565, La Jolla
uc davis medical center - patient support services building /ID# 265554, Sacramento

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Gastro Care Institute, Lancaster
United Gastroenterologists, Los Alamitos
a 3 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Southern California Research Center, Coronado
Om Research, LLC 1, Lancaster
a 6 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

United Medical Doctors, Murrieta
UCI Health, Orange

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Smart Cures Clinical Research, Anaheim
Cedars-Sinai Medical Center, Beverly Hills
United Medical Doctors - Los Alamitos, Los Alamitos
a 1 ďalších

Prebieha náborFáza 3

Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937099

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of California Davis Comprehensive Cancer Center, Sacramento

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Alliance Research Institute-Site Number: 8400008, Canoga Park
Southern California GI & Liver Centers-Site Number: 8400062, Coronado
Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
a 14 ďalších

Prebieha náborFáza 3

Vek 16 až 80 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05995353

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Gastro Care Institute, Lancaster
Infinity Clinical Research, San Diego

Prebieha náborFáza 2

Vek 18 až 85 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Biopharma Informatic, LLC, Los Angeles
Om Research LLC, Oxnard

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

UCSF Medical Center at Mission Bay, San Francisco

Prebieha náborFáza 3

Vek 2 až 19 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Biopharma Informatic, LLC, Los Angeles
Om Research LLC, Oxnard

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

University of California San Diego Health (UCSD), La Jolla
Cedars-Sinai Medical Center, Los Angeles
Hoag Hospital Newport Beach, Newport Beach

Prebieha náborFáza 4

Vek 18 až 70 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Gastro SB Clinic, Chula Vista
United Medical Doctors, Los Alamitos
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07577843

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Cedars Sinai Medical Center, Los Angeles

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT05509777

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Hoag Hospital, Irvine
UC San Diego Health, La Jolla
Cedars-Sinai, Los Angeles
a 1 ďalších

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT05230173

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Children's Hospital Of Orange County, Orange

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06100289

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
Lucile Packard Children's Hospital /ID# 262193, Palo Alto

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 24. 6. 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Loma Linda University, Loma Linda
Children's Hospital of Orange County, Orange
Stanford Children's Health, Palo Alto

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06405087

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Cedars-Sinai Medical Center, Beverly Hills

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 5. 6. 2026 · NCT06976853

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Cedars-Sinai, Los Angeles
UCSF Benioff Children's Hospitals, San Francisco

Prebieha náborFáza 4

Vek 6 až 17 · Všetky pohlavia · Aktualizované 27. 5. 2026 · NCT05781152

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

UCSD Medical Center, La Jolla
Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles

Prebieha náborFáza 3

Vek 18 až 65 · Všetky pohlavia · Aktualizované 27. 5. 2026 · NCT06227910

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Rady Children's Hospital - San Diego - PIN, San Diego

Prebieha náborFáza 3

Vek 2 a viac · Všetky pohlavia · Aktualizované 7. 5. 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

Children's Hospital of Los Angeles, Los Angeles
Lucile Packard Children's Hospital Stanford, Palo Alto
Rady Children's Hospital San Diego, San Diego

Prebieha náborFáza 2/3

Vek 6 až 22 · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Rady Childrens Hospital San Diego - PIN, San Diego

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Hoag Hospital, Irvine
United Medical Doctors, Murrieta

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 27. 4. 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Investigational Site Number: 8400005, Escondido
Investigational Site Number: 8400001, Lancaster

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT06958536

Effect of Statins on Crohn's Disease

Stanford University, Stanford

Prebieha náborSkorá fáza 1

Vek 18 až 80 · Všetky pohlavia · Aktualizované 27. 2. 2026 · NCT06538649

Impact of Prebiotics in Ulcerative Colitis

UCLA, Los Angeles

Prebieha nábor

Vek 18 až 85 · Všetky pohlavia · Aktualizované 27. 2. 2026 · NCT06495658

Stem Cell Transplantation in Crohn's Disease

Cedars-Sinai Medical Center, Los Angeles

Prebieha náborFáza 1/2

Vek 13 až 28 · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT04224558

Treatment of Moderate to Severe Refractory Crohn's Disease

University of California, Davis, Sacramento
University of California, San Francisco, San Francisco

Prebieha náborFáza 1/2

Vek 18 až 65 · Všetky pohlavia · Aktualizované 10. 12. 2025 · NCT06721962

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

University of California, San Diego, La Jolla

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Ženy · Aktualizované 28. 1. 2025 · NCT02103361

Urine Metabolites in the Diagnosis of Disease

Unio Health Partners (Gastroenterology), Encinitas
Digestive Health Associates, Santa Monica
Westside Gastro Care, Santa Monica
a 1 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 12. 2024 · NCT06710067

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.